Carcinoma of the Adrenal Cortex

Area of Science:

• Endocrinology
• Surgical Oncology
• Oncology

Background:

• Adrenal cortical carcinoma (ACC) is a rare malignancy with a generally poor prognosis, affecting all demographics.
• Approximately half of ACCs are functional, producing hormones, while the other half are non-functional.
• Early-stage ACC is infrequently diagnosed and often found incidentally or through endocrine manifestations.

Purpose of the Study:

• To review the current understanding of adrenal cortical carcinoma diagnosis and management.
• To emphasize the importance of radical surgical excision for curative intent.
• To highlight the need for further research into adjunctive therapies.

Main Methods:

• Review of existing literature on adrenal cortical carcinoma.
• Discussion of diagnostic modalities including imaging (CT scan, arteriography, venography) and endocrine evaluations.
• Analysis of surgical approaches and potential adjunctive treatments.

Main Results:

• Radical surgery with wide margins is the primary treatment for most adrenal tumors, excluding specific small, hormonally active tumors.
• Surgical interventions may involve extensive procedures like thoracoabdominal incisions and organ resections.
• The efficacy of adjunctive chemotherapy or radiation has not been established, and Ortho-p-DDD shows limited benefit.

Conclusions:

• Curative outcomes for adrenal cortical carcinoma are primarily observed in patients with widely-excised, low-stage tumors (T1-2 NOMO) without metastasis.
• Endocrine evaluations, while informative, should not delay surgical intervention.
• There is a critical need for Phase II and collaborative studies to evaluate combined chemotherapy treatments for adrenal cortical carcinoma.